Your browser doesn't support javascript.
loading
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma.
Taus, Álvaro; Camacho, Laura; Rocha, Pedro; Hardy-Werbin, Max; Pijuan, Lara; Piquer, Gabriel; López, Eva; Dalmases, Alba; Longarón, Raquel; Clavé, Sergi; Salido, Marta; Albanell, Joan; Bellosillo, Beatriz; Arriola, Edurne.
Afiliación
  • Taus Á; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain; Universidad Autónoma de Barcelona (UAB), Barcelona, Spain; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Camacho L; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Rocha P; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain.
  • Hardy-Werbin M; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Pijuan L; Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Piquer G; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, Hospital del Mar, Barcelona, Spain.
  • López E; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Dalmases A; Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Longarón R; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Clavé S; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Salido M; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Albanell J; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Bellosillo B; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Arriola E; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. Electronic address: earriola@parcdesalutmar.cat.
Clin Lung Cancer ; 19(5): 387-394.e2, 2018 09.
Article en En | MEDLINE | ID: mdl-29656868
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN de Neoplasias / Protocolos de Quimioterapia Combinada Antineoplásica / Ácidos Nucleicos Libres de Células / Neoplasias Hepáticas / Neoplasias Pulmonares / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN de Neoplasias / Protocolos de Quimioterapia Combinada Antineoplásica / Ácidos Nucleicos Libres de Células / Neoplasias Hepáticas / Neoplasias Pulmonares / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: España